Pacific Ethanol Inc (PEIX)

tuesday, december 1, 2009

Pacific Ethanol Inc (PEIX)

Pacific Ethanol Inc (PEIX): last weeks news that production could pick up significantly has sent the price of PEIX shares from .585/shr to 1.01/shr as the volume went from the ave 519k/day to 13.6m today

Pacific Ethanol Inc. could resume ethanol production at its 60 million-gallon-a-year facility in Burley, Idaho.

Sacramento-based Pacific Ethanol (Nasdaq: PEIX) suspended production of ethanol at the plant in February because of unfavorable market conditions for producing ethanol. Now, the company could begin production as early as January.

The company put much of its operation into bankruptcy protection in May. This year, the company halted three of its four production plants — in Burley, Idaho; Madera and Stockton. Only a plant in Boardman, Ore., is still operating.

Pacific Ethanol also owns 42 percent of Front Range Energy LLC, a plant in Windsor, Colo.

The plants combined have an operating capacity of 220 million gallons a year.

The company could restart the plant because of the expected increased demand for ethanol production in California, from about 950 million gallons this year to about 1.6 billion gallons in 2010. Gasoline sold in California is blended with almost 6 percent ethanol, and that will increase to 10 percent next year.

However, a restart of production at the Burley plant in January depends on a number of factors, including approval by the bankruptcy court, rehiring and training staff, and restocking corn and other raw materials. Pacific Ethanol’s ethanol-producing divisions filed for bankruptcy protection, but not the parent — and publicly traded — company.

The bankruptcy court is set to consider the matter Dec. 14.

Pacific Ethanol produced 40 million gallons of ethanol last year in California, before the plants were idled, according to the California Energy Commission.

Join Me at i5

Join Me at i5
make money for clicking on ads and have built a team of over 200 people, I also get paid when they click ads. How did I do this, all I did was share the idea, its free to join.
http://joini5.com/john

Pacific Ethanol Inc (PEIX)

Pacific Ethanol Inc (PEIX): last weeks news that production could pick up significantly has sent the price of PEIX shares from .585/shr to 1.01/shr as the volume went from the ave 519k/day to 13.6m today

Pacific Ethanol Inc. could resume ethanol production at its 60 million-gallon-a-year facility in Burley, Idaho.

Sacramento-based Pacific Ethanol (Nasdaq: PEIX) suspended production of ethanol at the plant in February because of unfavorable market conditions for producing ethanol. Now, the company could begin production as early as January.

The company put much of its operation into bankruptcy protection in May. This year, the company halted three of its four production plants — in Burley, Idaho; Madera and Stockton. Only a plant in Boardman, Ore., is still operating.

Pacific Ethanol also owns 42 percent of Front Range Energy LLC, a plant in Windsor, Colo.

The plants combined have an operating capacity of 220 million gallons a year.

The company could restart the plant because of the expected increased demand for ethanol production in California, from about 950 million gallons this year to about 1.6 billion gallons in 2010. Gasoline sold in California is blended with almost 6 percent ethanol, and that will increase to 10 percent next year.

However, a restart of production at the Burley plant in January depends on a number of factors, including approval by the bankruptcy court, rehiring and training staff, and restocking corn and other raw materials. Pacific Ethanol’s ethanol-producing divisions filed for bankruptcy protection, but not the parent — and publicly traded — company.

The bankruptcy court is set to consider the matter Dec. 14.

Pacific Ethanol produced 40 million gallons of ethanol last year in California, before the plants were idled, according to the California Energy Commission.

MY OPINION

Several times a week we locate issues that have for good reason or for no reason at all have had a significant increase in price and huge jumps in volume. The fact is that stocks go up and down. What we try to showcase are stocks that are active, money is made or lost on stocks that move. The key is to watch stocks that jump wait for them to correct then get in. Especially when stocks move up for no real reason at all. When stocks move due to fundamental improvement then there is a good chance that the issue is going to create a new plateau and move up. Hope this helps. Remember the key to making money in speculative stocks is buy near the trading lows. A rule of thumb that I like to follow is to find the issues that carry volume and buy them when they are no higher then 20% above the 52 week low price. We all have our methods this is a key one for me. I also never by a spec stock without checking out the CEO's background. If they have been successful before they are likely to do it again. And for heavens sake never buy stock in a company you can't call during normal business hours and talk to someone.

Advanced Medical Inst Inc (AVMD)

Here's why I love this business, on the release of the financial report below the vol that ave 1914 shr/day jumped to 2,629,313 and shares went up from .04 to .231 approaching the 52 week high of .28, hey don't ask me why, look for a huge rebound. PERIOD ENDING 30-Jun-09 31-Mar-09 31-Dec-08 30-Sep-08 total Revenue 10,975 13,217 13,211 15,949 Cost of Revenue 3,284 3,292 2,790 3,591 Gross Profit 7,690 9,925 10,421 12,358 Operating Expenses Research Development - - - - Selling General and Administrative 12,885 12,057 9,867 11,808 Non Recurring 5,279 - - - Others - - - - Total Operating Expenses - - - - Operating Income or Loss (10,474) (2,133) 554 550 Income from Continuing Operations Total Other Income/Expenses Net (47) 6 6 55 Earnings Before Interest And Taxes (10,455) (2,195) 562 606 Interest Expense 8 79 58 72 Income Before Tax (10,463) (2,275) 504 534 Income Tax Expense (2,971) (325) 162 374 Minority Interest - - - - Net Income From Continuing Ops (7,558) (1,881) 340 160 Non-recurring Events Discontinued Operations (340) (68) 47 (45) Extraordinary Items - - - - Effect Of Accounting Changes - - - - Other Items - - - - Net Income (7,897) (1,949) 387 115 Preferred Stock And Other Adjustments - - - - Net Income Applicable To Common Shares ($7,897) ($1,949) $387 $115

---

Origin Agritech Ltd (SEED)

On positive product news the shares went from $5.21 to $10.77 on huge volume of 45.5m shares.

BEIJING (TheStreet) -- Origin Agritech (SEED Quote) and Agria (GRO Quote) shares surged Monday on heavy volume after the former said it received Chinese commercial approval of its genetically modified phytase corn.Origin Agritech said Saturday its product is the "world's first genetically modified phytase corn" to be cleared for sale after the company received the Bio-safety Certificate from China's Ministry of Agriculture as a final approval. This is the last of five separate stages that genetically modified seed products must undergo in China, the company said.

Phytase is currently used as an additive in animal feed to breakdown phytic acid in corn. Origin Agritech's product will eliminate the need for animal feed producers to mix the two ingredients together, saving time, machinery, and labor for the animal feed producers, Origin said.

Shares of Origin Agritech were jumping by $3.75, or 72%, to $8.96. Earlier in the session, the stock touched an intraday high of $9. More than 6.7 million shares changed hands by 10:30 a.m. EDT Monday, compared to the stock's 50-day average daily volume of 189,000, according to the Nasdaq.

InstaCare Corp (ISCR)

InstaCare Corp. (ISCR.OB) :the shares ran from a previous close of .048 to todays close at .129, the volume soared form the average of 265k/day to over 12.9m on the financial news release. The following is the revenue report to see the entire report go to yahoo finance.

for the three months ended September 30, 2009 was $4,491,831 compared to revenue of $3,439,271 in the three months ended September 30, 2008. This resulted in an increase in revenue of $1,052,560, or 31%, from the same period a year ago. The increase in revenue over the three months ended September 30, 2008 was a result of our market focus toward direct sale and direct to patient sale of diabetic test strips and medical-surgical products into several medical channels.

Cost of sales/Gross profit percentage of sales

Our cost of sales for the three months ended September 30, 2009 was $4,180,868, an increase of $947,488, or 29% from $3,233,370 for the three months ended September 30, 2008. The increase in cost of sales during the current period was due to changes and decreases in the national Medicare reimbursement and the company's focus on increasing sales over the prior quarter in our direct to patient market sales.

Gross profit as a percentage of sales increased from 6% for the three months ended September 30, 2008 to 7% for the three months ended September 30, 2009. The decrease in gross profit margin was caused by three market forces; (a) a change in our product mix whereby we increased our sales levels in medical surgical sales markets to extended care facilities, which historically have a lower profit margin, (b) a lowered reimbursement allowed by the federal Medicare program and private insurers, and (c) a deteriorated economy which has lowered our ability to push "stock up" behavior among our patients.